Effective Management of Acute and Chronic Pain with Opioid Analgesics, 2nd Edition _ ________________
4. A licensee shall maintain competent records of completed qualified continuing professional education for a period of two years after close of the two-year period to which the records pertain. a. The Division may review controlled substance
11. as a pharmacy, failing to seek to correct a technical difficulty or electronic failure under Subsection 58-37- 22(1)(d) that is reasonably within the pharmacy’s control. R156-37-601. Access to Records, Facilities, and Inventory. During regular business hours, and at other reasonable times, each applicant for licensure and licensee shall make available for inspection to a person authorized to conduct an administrative inspection under federal law, Title 58, Chapter 37, Utah Controlled Substances Act, or Rule R156-37, their: 1. controlled substance stock or inventory; 2. records required in accordance with state and federal laws and rules; and 3. facilities related to activities involving controlled substances. R156-37-602. Records. 1a. Records of controlled substances shall be kept in accordance with state and federal laws and
database usage by the prescriber or proxy to audit an attestation under Subsection (3)(c).
R156-37-502. Unprofessional Conduct. “Unprofessional conduct” includes: 1. as a licensee with authority to prescribe or administer controlled substances: a. prescribing or administering to oneself any Schedule II or III controlled substance that is not lawfully prescribed by another licensed practitioner having authority to prescribe the drug; b. prescribing or administering a controlled substance for a condition that the licensee is not licensed or competent to treat; 2. violating a federal or state law relating to controlled substances; 3. failing to deliver to the Division each controlled substance license certificate issued by the Division upon an action that revokes, suspends, or limits the license; 4. failing to maintain controls over controlled substances that a prudent licensee would maintain as effective against diversion, theft, or shortage of controlled substances; 5. failing to account for shortages of controlled substance inventory for which the licensee has responsibility; 6. knowingly prescribing, selling, giving away, or administering, directly or indirectly, or offering to prescribe, sell, furnish, give away, or administer any controlled substance to a drug dependent person, as defined in Subsection 58-37-2(1)(s), except for legitimate medical purposes as permitted by law; 7. refusing to make available for inspection controlled substance stock, inventory, or records as required under Rule R156-37 or other law regulating controlled substances and controlled substance records; 8. failing to submit controlled substance prescription information to the Database Manager after being notified in writing by the Division to do so; 9. failing to get a DEA registration within the time frame in Section R156-37-305; 10. as a prescribing practitioner, failing to seek to correct a technical difficulty or electronic failure under Subsection 58-37-22(1)(d) that is reasonably within the prescribing practitioner’s control; or
rules for their: i. purchase; ii. distribution; iii. dispensing;
iv. prescribing and v. administration. b. Prescribing practitioners shall keep accurate records for each patient reflecting: i. examination; ii. evaluation; and iii. treatment. c. Patient medical records shall: i. accurately reflect the prescription or administration of controlled substances in the treatment of the patient; ii. the purpose for which the controlled substance is utilized; and iii. information upon which the diagnosis is based. d. Practitioners shall keep records apart from patient records of each controlled substance purchased, and with respect to each controlled substance, its disposition, whether by administration or any other means, date of disposition, to whom given, and the quantity given. 2. A licensee who experiences any theft, including diversion, or significant loss of controlled substances shall immediately: a. file the appropriate forms with the DEA,
with a copy to the Division directed to the attention of the Investigation Bureau; and
32
MDUT1125
Powered by FlippingBook